With 2900 volunteers, a United Stated developed vaccine called NVX-CoV2373 by a company called Novavax will be launched in South Africa today. Volunteers will be getting the vaccine in two doses, three weeks apart during the clinical trial
Professor of Vaccinology Shabir Mahd at University of the Witwatersrand explained that as South Africa accounts for 20 percent of the global HIV infections, 240 medically fit volunteers will also take part in the Clinical trial.
The clinical trial is supported by the Bill And Melinda Gates foundation with a 15 million dollars grant. Professor Mahdi will be leading the clinical trial.
President Of Research And Development at Novavax, George M. Glenn, ssys that as South Africa is in the winter surge of Coronavirus, the clinical trial has the potential to be successful in conjunction with safety and immunogenicity data of the developed vaccine.
Glenn continued to say that the company is grateful for the support of Bill and Melinda Gates Foundation, CEPI and the collaboration it has with Wits University by working hand in hand with them to deliver a safe vaccine around the world.
Shouldn't any country that wants to test a vaccine start the tests at its home country? Why Africa? This is a second vaccine trial after the first one was launched in June. South Africa has become a country of vaccine trials.
South Africa already has a recovery rate of over 90 percent. Well, maybe this would be a proven vaccine that has the ability to save millions of lives. Bill gates is trying by all means to make sure it will be no one else but him who will provide a vaccine in South Africa.
Content created and supplied by: Sasanice (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More